drugset / Trial / NCT01872910

A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal

NCT01872910

Phase 2 Completed 124 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of this study is to test if a single dose of LY3023703 relieves pain after wisdom teeth removal. The study will last about one week for each participant, not including screening.

Timeline

Start
2013-06
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 400 mg Oral
Subject LY3023703 Unknown 30 mg Oral

Indications

No indication recorded.